# AstraZeneca (Finland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/astrazeneca-finland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 52 |
| Citations | 98,466 |
| City | Espoo |
| Country | FI |
| Description | AstraZeneca (Finland) is a research organisation in Espoo, FI. OpenAlex records 1,387 works and 98,466 citations for it. 871 researchers list it as their most recent affiliation. |
| Homepage | https://www.astrazeneca.fi/ |
| OpenAlex ID | https://openalex.org/I4210137263 |
| Researchers | 871 |
| ROR ID | https://ror.org/035n56j11 |
| Type | company |
| Works | 1,387 |

## University papers

Showing 12 of 15.

- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects](https://scholariq.org/papers/effects-of-bariatric-surgery-on-mortality-in-swedish-obese-subjects/)
- [Bariatric Surgery and Long-term Cardiovascular Events](https://scholariq.org/papers/bariatric-surgery-and-long-term-cardiovascular-events/)
- [Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial](https://scholariq.org/papers/effects-of-bariatric-surgery-on-cancer-incidence-in-obese-patients-in-sweden/)
- [Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study](https://scholariq.org/papers/reduction-in-incidence-of-diabetes-hypertension-and-lipid-disturbances-after/)
- [Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in/)
- [Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin](https://scholariq.org/papers/dapagliflozin-maintains-glycaemic-control-while-reducing-weight-and-body-fat/)
- [A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy](https://scholariq.org/papers/a-pre-specified-analysis-of-the-dapa-ckd-trial-demonstrates-the-effects-of/)
- [Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension](https://scholariq.org/papers/differentiated-long-term-effects-of-intentional-weight-loss-on-diabetes-and/)
- [Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region](https://scholariq.org/papers/clinical-implementation-of-artificial-intelligence-driven-cone-beam-computed/)
- [Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-urinary-albumin-excretion-in-patients-with-chronic/)
- [Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-the-rate-of-decline-in-kidney-function-in-patients/)

## University researchers

- [C. David Sjöström](https://scholariq.org/researchers/c-david-sjostrom/)

## University top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Inhalation and Respiratory Drug Delivery](https://scholariq.org/topics/inhalation-and-respiratory-drug-delivery/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.